RN181 suppresses hepatocellular carcinoma growth by inhibition of the ERK/MAPK pathway

Abstract

We have shown that RN181 suppresses the tumorigenesis of HCC through the inhibition of ERK/MAPK signaling in the liver. Our results provide new insights into the pathogenesis of HCC and may help with the development of novel therapeutic strategies.